MARKET

CDXC

CDXC

Chromadex Corp
NASDAQ
3.390
-0.010
-0.29%
After Hours: 3.360 -0.03 -0.89% 16:06 04/25 EDT
OPEN
3.440
PREV CLOSE
3.400
HIGH
3.510
LOW
3.360
VOLUME
192.92K
TURNOVER
0
52 WEEK HIGH
4.650
52 WEEK LOW
1.250
MARKET CAP
255.30M
P/E (TTM)
-51.4416
1D
5D
1M
3M
1Y
5Y
ChromaDex Launches Tru Niagen At The Vitamin Shoppe
Benzinga · 7h ago
ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®
Tru Niagen, the number one healthy-aging NAD+ supplement in the United States, launches at The Vitamin Shoppe and Super Supplements. Tru Niagen is now available at 700 locations of The Vitamin shoppe retail locations nationwide and online at www.vitaminshoppe.com. This retail expansion adds consumer access to the highest-quality and most efficient NAD+ precursor.
Barchart · 12h ago
Press Release: ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 at 4:30 p.m. ET. The company will hold a conference call to discuss its financial results for the first quarter, which ended March 31, 2024. ChromaDex is the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research.
Dow Jones · 1d ago
ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
ChromaDex Corp. Will hold a conference call on May 8, 2024 to discuss its financial results for the first quarter, which ended March 31, 2024. ChromaDex is the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research. The company's flagship ingredient is the number one healthy-aging NAD+ supplement in the U.S.
Barchart · 1d ago
Weekly Report: what happened at CDXC last week (0415-0419)?
Weekly Report · 3d ago
Weekly Report: what happened at CDXC last week (0408-0412)?
Weekly Report · 04/15 11:59
ChromaDex Price Target Raised to $6.00/Share From $4.25 by Roth MKM
Dow Jones · 04/09 14:10
ChromaDex Is Maintained at Buy by Roth MKM
Dow Jones · 04/09 14:10
More
About CDXC
Chromadex Corp. is a global bioscience company. The Company is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients, commercialized as Tru Niagen, directly to consumers and distributors. The Ingredients segment develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Ingredients segment provides Niagen in ingredient form to its strategic partners. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.

Webull offers Chromadex Corp stock information, including NASDAQ: CDXC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDXC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDXC stock methods without spending real money on the virtual paper trading platform.